CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading organization profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Royal Prince Alfred Hospital - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Organizations/healthcare

healthcare organization

Royal Prince Alfred Hospital

AU

OPENALEX: I2799732068↗ROR: 05gpvde20↗

People

Connected researchers

Bridin MurnionORCID 0000-0001-7791-3025 Crispin CorteExact authorship link Jaleh GholamiORCID 0000-0002-3248-6207 Nazila JamshidiORCID 0000-0002-6049-9654 Paul HaberORCID 0000-0001-8915-8872 Ronald GrunsteinORCID 0000-0001-6682-5812 Wendy SwiftExact authorship link

Public evidence

6 connected articles

Evaluating possible 'next day' impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial.2024 · Europe PMC Different Tokes for Different Folks: Use of Cannabis Products Among a Longitudinal Cohort of People with Heroin Dependence.2023 · PubMed Central Open Access Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences, and Current Use in Australian Patients2020 · PubMed Central Open Access Attitudes and Knowledge of Australian Gastroenterologists Around the Use of Medicinal Cannabis for Inflammatory Bowel Disease2020 · PubMed Central Open Access Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.2019 · Europe PMC Detection of Δ<sup>9</sup> THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point-of-collection testing devices.2019 · Europe PMC

Matched by exact identifiers only. Profile data: OpenAlex.